<DOC>
	<DOC>NCT00259649</DOC>
	<brief_summary>Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.</brief_summary>
	<brief_title>Prospective Survey of Menstrual Migraine &amp; Prevention With Eletriptan</brief_title>
	<detailed_description>Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<criteria>age 1845 healthy menstruating female cardiac or other conditions precluding use of eletriptan</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>